Kestra Advisory Services, LLC

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1830819 AUSTIN, TX

Position in PTGX

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$620,377

+$87,686 QoQ

Shares Held

5,061

+0.1% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#198

of 341 holders

Holding Since

Mar 2021

11 quarters on record

Healthcare · as of Jun 30, 2026

Kestra Advisory Services, LLC holds $29,012,263 across 51 Biotechnology names. PTGX ranks #16 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	15,732	$7,814,556
2	REGN	Regeneron Pharmaceuticals, Inc.	2,893	$1,803,901
3	RPRX	Royalty Pharma plc	27,331	$1,532,449
4			39,421	$1,239,002
5	VKTX	Viking Therapeutics, Inc.	27,091	$1,056,819
6	IBRX	ImmunityBio, Inc.	110,630	$968,565
7	CORT	Corcept Therapeutics Inc	10,914	$948,972
8	CRSP	CRISPR Therapeutics AG	17,292	$943,105

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$620,377	5,061	+0.1%	Shares	Sole	2026-07-28
2026-03-31	$532,691	5,054	-1.7%	Shares	Sole	2026-04-30
2025-12-31	$449,102	5,142	-1.6%	Shares	Sole	2026-02-13
2025-09-30	$346,963	5,223	-9.4%	Shares	Sole	2025-11-14
2025-06-30	$318,521	5,763	+11.2%	Shares	Sole	2025-08-15
2025-03-31	$250,553	5,181	-8.3%	Shares	Sole	2025-05-14
2024-12-31	$217,974	5,647	+9.0%	Shares	Sole	2025-02-10
2024-09-30	$233,235	5,183	-33.8%	Shares	Sole	2024-11-13
2021-12-31	$267,888	7,833	-43.8%	Shares	Sole	2022-07-25
2021-06-30	$625,582	13,939	+2.3%	Shares	Sole	2022-07-26
2021-03-31	$352,991	13,629	—	Shares	Sole	2022-07-27
No filing history on record for this holder in this stock.